Jones Day is a global law firm with more than 2,500 lawyers across five continents. The Firm is distinguished by a singular tradition of client service; the mutual commitment to, and the seamless collaboration of, a true partnership; formidable legal talent across multiple disciplines and jurisdictions; and shared professional values that focus on client needs.
In the April 7, 2015, Federal
Register, FDA announced it has issued a priority
review voucher for Cholbam (cholic acid), pursuant to authority
provided in the Food and Drug Administration Safety and Innovation
Act. Cholbam is a bile acid indicated for the treatment of bile
acid synthesis disorders and other peroxisomal disorders.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
